Breadcrumb

What’s new at The Institute?

Circadian rhythms appear to influence vulnerability to malaria parasites

A new discovery could lead to more effective treatment of malaria and other parasitic diseases.

Introducing peanuts earlier to reduce allergy risk

A recent study by the Research Institute of the McGill University Health Centre, using data from the Montreal Children's Hospital, reveals that introducing...

Dream discovery: Melatonin’s key role in REM sleep revealed

A significant breakthrough in the understanding of sleep mechanism opens new promise for treating sleep disorders and associated...

A first-ever effective therapy for rare devastating neurodegenerative diseases

With the support of a nonprofit organization started by a patient’s family, rare disease expert Dr. Kenneth Myers...

Triple-negative breast cancer: new hope for an existing drug

RI-MUHC team takes another step toward precision medicine by targeting a biomarker of CDK4/6 inhibitor efficacy in breast cancer, including triple-negative...

Prescribing personalized lifestyle interventions to improve prostate cancer treatments

David Labbé of the RI-MUHC co-leads a new project recently funded by the Marathon of Hope Cancer Centres...

$2 million dollars awarded to RI-MUHC team studying lung health

Dr. Benjamin Smith receives CIHR funding to lead research on inflammation and lung health in diverse populations

McGill, industry, CQDM and Brain Canada collaborate for drug discovery

Novel drug could provide hope to those suffering from neuropathic pain and insomnia

Learn more about the RI-MUHC